Tag - AIFF

Developments

Arrivo unveils positive study results on SP-624’s impact on depression and cognition

Closely held Arrivo BioVentures has announced promising results from its study evaluating SP-624’s novel epigenetic mechanism of action on neurological pathways. According to the company, the findings provide insights...

January 10, 2025

Tag - AIFF

Arrivo unveils positive study results on SP-624’s impact on depression and cognition

General

More